Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Preventive AIDS vaccine trial to begin in Thailand

Feb. 18, 1999

Ligand introduces second new product this month

Feb. 17, 1999

Abbott is also recipient of Prix Galien for its protease inhibitor

Feb. 17, 1999

Agouron presents Women First study results at ROI conference

Feb. 16, 1999

U.S. university researchers claim anti-HIV 2',5'-phosphorothioate/phosphodiester oligoadenylates

Feb. 15, 1999

Protease inhibitors awarded 1998 Prix Galien

Feb. 15, 1999

SIV isolates from chimpanzees closely related to HIV-1

Feb. 15, 1999

Pediatric study supports use of vCP205 in infants born to HIV-positive mothers

Feb. 12, 1999

T-140, a potent CXCR4-dependent inhibitor of HIV infection

Feb. 12, 1999

Glaxo presents new NNRTI from quinoxaline class that has progressed to human trials

Feb. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...